GALE encodes UDP-galactose-4-epimerase, and mutations in GALE result in epimerase-deficient galactosemia, also referred to as galactosemia type 3, a disease characterized by early onset cataracts, liver damage, deafness, and mental retardation [38]. Here, GALE is linked to cataract.